VMAT2 Inhibitors: Valbenazine (Ingrezza) and Deutetrabenazine (Austedo)
PsychRounds: The Psychiatry Podcast
00:00
Why tetrabenazine wasn't approved for TD
Tanner Hewitt discusses tetrabenazine limitations: short half-life, TID dosing, and lack of patent incentives for TD approval.
Play episode from 05:31
Transcript
